CDC recommendations for influenza antiviral medications remain unchanged
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i

CDC recommendations for influenza antiviral medications remain unchanged

Filetype[PDF-1.36 MB]


  • English

  • Details:

    • Description:
      February 09, 2012, 15:00 EST CDCHAN-00324-ADV-N A recent review of randomized clinical trial data for the influenza neuraminidase inhibitor antiviral medications, and two related commentaries, raised questions about the value of antiviral medications for the prevention and treatment of influenza. On February 7, 2012, the Centers for Disease Control and Prevention (CDC) posted a "Have You Heard?" piece in response. The CDC response states "After careful consideration of all available evidence, CDC guidance on the use of antiviral medications remains unchanged." CDC continues to recommend the use of neuraminidase inhibitor antiviral drugs (oral oseltamivir and inhaled zanamivir) as an important adjunct in the prevention and treatment of influenza.
    • Series:
    • Document Type:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov